Moreover, compared with alisertib-treated mice, the CD45+CD11b+F4/80+ cells in tumor tissue from β-glucan-trained mice showed a higher intracellular phospho-S6, suggesting that AurA inhibition inhibited mTOR activation in TAMs (Figure 6G). Here, PTPRC is linked to neoplasm.